Posttranslational modification of β-catenin is associated with pathogenic fibroblastic changes in bronchopulmonary dysplasia
- 1 February 2017
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 312 (2) , L186-L195
Abstract
Bronchopulmonary dysplasia (BPD) is a common complication of premature birth. The histopathology of BPD is characterized by an arrest of alveolarization with fibroblast activation. The Wnt/β-catenin signaling pathway is important in early lung development. When Wnt signaling is active, phosphorylation of β-catenin by tyrosine kinases at activating sites, specifically at tyrosine 489 (Y489), correlates with nuclear localization of β-catenin. We examined fetal lung tissue, lung tissue from term newborns, and lung tissue from infants who died with BPD; we found nuclear β-catenin phosphorylation at Y489 in epithelial and mesenchymal cells in fetal tissue and BPD tissue, but not in the lungs of term infants. Using a 3D human organoid model, we found increased nuclear localization of β-catenin phosphorylated at Y489 (p-β-cateninY489) after exposure to alternating hypoxia and hyperoxia compared with organoids cultured in normoxia. Exogenous stimulation of the canonical Wnt pathway in organoids was sufficient to cause nuclear localization of p-β-cateninY489 in normoxia and mimicked the pattern of α-smooth muscle actin (α-SMA) expression seen with fibroblastic activation from oxidative stress. Treatment of organoids with a tyrosine kinase inhibitor prior to cyclic hypoxia-hyperoxia inhibited nuclear localization of p-β-cateninY489 and prevented α-SMA expression by fibroblasts. Posttranslational phosphorylation of β-catenin is a transient feature of normal lung development. Moreover, the persistence of p-β-cateninY489 is a durable marker of fibroblast activation in BPD and may play an important role in BPD disease pathobiology.Keywords
Funding Information
- California Institute of Regenerative Medicine (CIRM) (TG2-01169)
- HHS | NIH | National Institute of Child Health and Human Development (NICHD) (HD087023)
- California Institute for Regenerative Medicine (CIRM) (12-02)
- HHS | NIH | National Institute of General Medical Sciences (NIGMS) (GM114259-01, GM108807)
- National Science Foundation (NSF) (DGE-1144087)
This publication has 38 references indexed in Scilit:
- Searching for better animal models of BPD: a perspectiveAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2016
- Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertensionJournal of Clinical Investigation, 2016
- Csk/Src/EGFR signaling regulates migration of myofibroblasts and alveolarizationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2016
- Animal models of bronchopulmonary dysplasia. The preterm baboon modelsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2014
- Bronchopulmonary Dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung DiseasesAnnals of the American Thoracic Society, 2014
- Altered lung development in bronchopulmonary dysplasiaBirth Defects Research Part A: Clinical and Molecular Teratology, 2014
- The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancerHuman Pathology, 2012
- FGF-10 is decreased in bronchopulmonary dysplasia and suppressed by Toll-like receptor activationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Wnt/β-catenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal–distal patterning in the lungDevelopmental Biology, 2005
- Control Mechanisms of Lung Alveolar Development and Their Disorders in Bronchopulmonary DysplasiaPediatric Research, 2005